Vanda Pharmaceuticals Shareholder ShareCap Says Company Board Must Explore Strategic Alternatives
Vanda Pharmaceuticals Shareholder ShareCap Says Company Board Must Explore Strategic Alternatives
萬達製藥股東ShareCap表示公司董事會必須探索戰略替代方案
ShareCap calls on the Board to initiate a strategic alternatives process that, among the alternatives, reconsiders Future Pak's offer.
ShareCap呼籲董事會啓動戰略備選方案，該流程包括重新考慮Future Pak的提議。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。